Profile_bird

Hey there! GENbio is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving GENbio's tweets.

Already using Twitter
from your phone? Click here.

GENbio

  1. Quantum Immunologics to Commercialize Auburn University’s Veterinary Cancer Immunotherapy http://bit.ly/7DlOd8 12:15 PM Nov 25th from TweetDeck
  2. Labopharm Secures Access to C$25 Million http://bit.ly/8zzCR8 10:36 AM Nov 25th from TweetDeck
  3. Researchers Identify Phosphorylation Signatures of Lung Cancer http://bit.ly/6jAi85 10:04 AM Nov 25th from TweetDeck
  4. Novartis Shells Out $210M for Two of Incyte’s Hematology-Oncology Candidates http://bit.ly/70ZI2X 9:43 AM Nov 25th from TweetDeck
  5. Sinovac Expands Vaccine Capabilities with New JV http://bit.ly/4qOfcS 9:16 AM Nov 25th from TweetDeck
  6. Oxagen Raises £16M to Continue Clinical Development of CRTH2 Antagonist against Asthma http://bit.ly/4oZr6J 8:43 AM Nov 25th from TweetDeck
  7. Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility http://bit.ly/4sf6Nv 8:41 AM Nov 25th from TweetDeck
  8. Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility http://bit.ly/8XuNOW 8:41 AM Nov 25th from TweetDeck
  9. Good and Bad News at Idera http://bit.ly/6hvGUV 8:16 AM Nov 25th from TweetDeck
  10. Poniard’s Fortunes Likely Rest on Picoplatin http://bit.ly/5eEyN4 7:11 AM Nov 25th from TweetDeck
  11. Roche Earmarks €4M for Rare Disease Collaboration with Andalucian Region's DoH http://bit.ly/6DNAG6 12:44 PM Nov 24th from TweetDeck
  12. Gilead and GlaxoSmithKline Divvy Up Commercialization of Viread® for HBV in Key Asian Countries http://bit.ly/80fybM 12:34 PM Nov 24th from TweetDeck
  13. Clovis Negotiates Potentially $380M Deal to Develop Clavis Pharma’s Lipid-Conjugated Gemcitabine http://bit.ly/8j9GZs 10:11 AM Nov 24th from TweetDeck
  14. Commemorating the Anniversary of the Publication of “On the Origin of Species” http://bit.ly/5QXCv5 8:51 AM Nov 24th from TweetDeck
  15. Movetis Launches €112.4 IPO on Euronext Belgium http://bit.ly/70UVXd 12:48 PM Nov 23rd from TweetDeck
  16. Researchers Discover Potential Mechanism for Preventing Cell Death After Stroke http://bit.ly/7E4bP4 12:15 PM Nov 23rd from TweetDeck
  17. Millipore Acquires Remaining Ownership of India JV http://bit.ly/5WHtTo 10:54 AM Nov 23rd from TweetDeck
  18. New Uncertainty Regarding Disclosure of Adverse Effects http://bit.ly/4Egh88 10:43 AM Nov 23rd from TweetDeck
  19. NexMed Nabs Bio-Quant to Expand Preclinical Capabilities http://bit.ly/8u1Hr6 10:03 AM Nov 23rd from TweetDeck
  20. Check out http://www.genengnews.com/e... for the latest Cryptogram Challenge: ELISA Redux clue. 9:17 AM Nov 23rd from TweetDeck
  • Name GEN Online
  • Location New Rochelle, NY
  • Web http://www.geneng...
  • Bio Count on Genetic Engineering and Biotech News as your life science insider. Our timely and exhaustive coverage includes news, analysis, blogs, and podcasts.
74 Following 878 Followers 35 Listed
Human Microbiome Inst Genome Sciences Adam Etkin Cory Tromblee Lisa Haile Cory Pigeon Sophia Fox AstraZenecaUS AstraZeneca PR Jeremy Schoemaker Doug Mitchell Mary Ann Liebert BLOWOUTCARDS BIO Intl Convention I Am Biotech MD Biosciences Boehringer BioTek Instruments BD Biosciences Bio-Rad Laboratories Agilent Technologies AAPS Alfie Steven Watterson Salk Institute Roche AG promega Gabriela Saldanha mf clampitt RocheAppliedScience Nico Tuason Kathy Mackey Lisa Petrilli Boomerang Pharma Bertalan Meskó, MD Jennifer Schlegel